Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Gross Profit 2009–2025
Celldex Therapeutics Inc. annual/quarterly gross profit history and growth rate from 2016 to 2025. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Celldex Therapeutics Inc. annual gross profit for 2025 was 1.3 M, a 80.28% decrease from 2024.
- Celldex Therapeutics Inc. annual gross profit for 2024 was 6.8 M, a 3.60% increase from 2023.
- Celldex Therapeutics Inc. annual gross profit for 2023 was 6.6 M, a 191.67% increase from 2022.
- Celldex Therapeutics Inc. annual gross profit for 2022 was 2.3 M.
No data available.
Celldex Therapeutics Inc. Gross Profit — FAQ
Celldex Therapeutics Inc. (CLDX) gross profit over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Celldex Therapeutics Inc.'s gross profit?
Celldex Therapeutics Inc. (CLDX) reported gross profit of $1M for fiscal 2025.
Where can I see CLDX's gross profit history?
The chart and table above show Celldex Therapeutics Inc.'s gross profit by year and by quarter, including the growth rate.